secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dare Bioscience, Inc. (DARE)
CIK:        0001401914
Form:       8-K
Filed at:   2026-04-17T23:59:59+00:00
Accession:  0001401914-26-000010
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Gregory W. Matz reclassified from Class II to Class III director to rebalance board classes
--------------------------------------------------------------------------------

- Matz resigned as Class II director and was reappointed as Class III director effective April 16, 2026.
- Reclassification was solely to rebalance the three board classes; service deemed uninterrupted.
- Board remains at six members; Matz and Sabrina Martucci Johnson will stand for election at 2026 annual meeting.
- No changes to Matz's committee assignments as a result of the reclassification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401914/000140191426000010/0001401914-26-000010-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401914/000140191426000010/dare-20260416.htm
  HTML page:      https://secwatch.observer/filing/0001401914-26-000010

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer